Clinical trials for the treatment of coronavirus disease 2019(COVID-19):A rapid response to urgent need

作     者：Tengyue Zhang Yudi He Wenshuai Xu Aiping Ma Yanli Yang Kai-Feng Xu Tengyue Zhang;Yudi He;Wenshuai Xu;Aiping Ma;Yanli Yang;Kai-Feng Xu

作者机构：Department of Internal MedicinePeking Union Medical College HospitalChinese Academy of Medical SciencesBeijing 100730China Department of Pulmonary and Critical Care MedicinePeking Union Medical College HospitalChinese Academy of Medical SciencesBeijing 100730China Department of Pulmonary and Critical Care MedicineThe First Affiliated HospitalCollege of MedicineXiamen UniversityXiamen 361003China 

出 版 物：《Science China(Life Sciences)》 (中国科学（生命科学英文版）)

年 卷 期：2020年第63卷第5期

页      面：774-776页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：Children’s Hospital at Westmead U.S. Food and Drug Administration, FDA Peking Union Medical College Hospital, PUMCH 

主　　题：Clinical treatment COV 

摘      要：Emerging coronavirus disease 2019,known as COVID-19,is caused by the newly identified SARS-CoV-2 *** the outbreak of COVID-19 in December 2019 in Wuhan(China),more than 70 thousand patients were *** disease resulted in 1,870 deaths by February 18,2020,according to the National Health Commission of People s Republic of China(http://***).